Cargando…
EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma
For malignant pleural mesothelioma (MPM) novel therapeutic strategies are urgently needed. In a previous study, we identified 51 putative cancer genes over-expressed in MPM tissues and cell lines. Here, we deepened the study on nine of them (ASS1, EIF4G1, GALNT7, GLUT1, IGF2BP3 (IMP3), ITGA4, RAN, S...
Autores principales: | Dell’Anno, Irene, Barbarino, Marcella, Barone, Elisa, Giordano, Antonio, Luzzi, Luca, Bottaro, Maria, Migliore, Loredana, Agostini, Silvia, Melani, Alessandra, Melaiu, Ombretta, Catalano, Calogerina, Cipollini, Monica, Silvestri, Roberto, Corrado, Alda, Gemignani, Federica, Landi, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402288/ https://www.ncbi.nlm.nih.gov/pubmed/32659970 http://dx.doi.org/10.3390/ijms21144856 |
Ejemplares similares
-
Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma
por: Dell’Anno, Irene, et al.
Publicado: (2020) -
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma
por: Dell’Anno, Irene, et al.
Publicado: (2022) -
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines
por: Melaiu, Ombretta, et al.
Publicado: (2017) -
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
por: Morani, Federica, et al.
Publicado: (2021) -
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020)